Logo image of BIOX

BIOCERES CROP SOLUTIONS CORP (BIOX) Stock Price, Quote, News and Overview

NASDAQ:BIOX - Nasdaq - KYG1117K1141 - Common Stock - Currency: USD

4.63  +0.1 (+2.21%)

After market: 4.63 0 (0%)

BIOX Quote, Performance and Key Statistics

BIOCERES CROP SOLUTIONS CORP

NASDAQ:BIOX (5/23/2025, 9:15:55 PM)

After market: 4.63 0 (0%)

4.63

+0.1 (+2.21%)

Sector
GICS SectorMaterials
GICS IndustryChemicals
GICS IndustryGroupMaterials
GICS SubIndustryFertilizers & Agricultural Chemicals
Statistics
52 Week High11.86
52 Week Low3.51
Market Cap290.35M
Shares62.71M
Float33.68M
Yearly Dividend0
Dividend YieldN/A
PEN/A
Fwd PE27.51
Earnings (Next)N/A N/A
IPO03-22 2018-03-22


BIOX short term performance overview.The bars show the price performance of BIOX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20

BIOX long term performance overview.The bars show the price performance of BIOX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of BIOX is 4.63 USD. In the past month the price increased by 7.67%. In the past year, price decreased by -57.72%.

BIOCERES CROP SOLUTIONS CORP / BIOX Daily stock chart

BIOX Competitors/Peers

The largest stocks on the US markets in the "Fertilizers & Agricultural Chemicals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CTVA CORTEVA INC 24.75 47.17B
NTR NUTRIEN LTD 18.94 29.15B
CF CF INDUSTRIES HOLDINGS INC 12 14.80B
MOS MOSAIC CO/THE 19.29 11.13B
ICL ICL GROUP LTD 16.79 8.23B
FMC FMC CORP 11.62 4.77B
SMG SCOTTS MIRACLE-GRO CO 19.23 3.41B
UAN CVR PARTNERS LP 11.46 863.57M
IPI INTREPID POTASH INC 457.88 487.91M
AVD AMERICAN VANGUARD CORP N/A 119.19M
GRO BRAZIL POTASH CORP N/A 51.85M
ENFY ENLIGHTIFY INC N/A 13.73M

About BIOX

Company Profile

BIOX logo image Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The company is headquartered in Rosario, Santa Fe and currently employs 983 full-time employees. The company went IPO on 2018-03-22. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops.

Company Info

BIOCERES CROP SOLUTIONS CORP

Ocampo 210 bis, Predio CCT

Rosario SANTA FE 2000 AR

CEO: Federico Trucco

Employees: 389

BIOX Company Website

BIOX Investor Relations

Phone: 543414861100

BIOCERES CROP SOLUTIONS CORP / BIOX FAQ

What is the stock price of BIOCERES CROP SOLUTIONS CORP today?

The current stock price of BIOX is 4.63 USD. The price increased by 2.21% in the last trading session.


What is the ticker symbol for BIOCERES CROP SOLUTIONS CORP stock?

The exchange symbol of BIOCERES CROP SOLUTIONS CORP is BIOX and it is listed on the Nasdaq exchange.


On which exchange is BIOX stock listed?

BIOX stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for BIOCERES CROP SOLUTIONS CORP stock?

10 analysts have analysed BIOX and the average price target is 7.78 USD. This implies a price increase of 67.98% is expected in the next year compared to the current price of 4.63. Check the BIOCERES CROP SOLUTIONS CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BIOCERES CROP SOLUTIONS CORP worth?

BIOCERES CROP SOLUTIONS CORP (BIOX) has a market capitalization of 290.35M USD. This makes BIOX a Micro Cap stock.


How many employees does BIOCERES CROP SOLUTIONS CORP have?

BIOCERES CROP SOLUTIONS CORP (BIOX) currently has 389 employees.


What are the support and resistance levels for BIOCERES CROP SOLUTIONS CORP (BIOX) stock?

BIOCERES CROP SOLUTIONS CORP (BIOX) has a support level at 4.62 and a resistance level at 4.72. Check the full technical report for a detailed analysis of BIOX support and resistance levels.


Is BIOCERES CROP SOLUTIONS CORP (BIOX) expected to grow?

The Revenue of BIOCERES CROP SOLUTIONS CORP (BIOX) is expected to decline by -19.62% in the next year. Check the estimates tab for more information on the BIOX EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BIOCERES CROP SOLUTIONS CORP (BIOX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIOCERES CROP SOLUTIONS CORP (BIOX) stock pay dividends?

BIOX does not pay a dividend.


What is the Price/Earnings (PE) ratio of BIOCERES CROP SOLUTIONS CORP (BIOX)?

BIOCERES CROP SOLUTIONS CORP (BIOX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.13).


What is the Short Interest ratio of BIOCERES CROP SOLUTIONS CORP (BIOX) stock?

The outstanding short interest for BIOCERES CROP SOLUTIONS CORP (BIOX) is 3.1% of its float. Check the ownership tab for more information on the BIOX short interest.


BIOX Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to BIOX. When comparing the yearly performance of all stocks, BIOX is a bad performer in the overall market: 84.97% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

BIOX Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to BIOX. Both the profitability and financial health of BIOX have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BIOX Financial Highlights

Over the last trailing twelve months BIOX reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS decreased by -551.72% compared to the year before.


Industry RankSector Rank
PM (TTM) 0.33%
ROA 0.18%
ROE 0.47%
Debt/Equity 0.47
Chartmill High Growth Momentum
EPS Q2Q%-114.29%
Sales Q2Q%-27.86%
EPS 1Y (TTM)-551.72%
Revenue 1Y (TTM)11.98%

BIOX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to BIOX. The Buy consensus is the average rating of analysts ratings from 10 analysts.

For the next year, analysts expect an EPS growth of -284.41% and a revenue growth -19.62% for BIOX


Ownership
Inst Owners21.08%
Ins Owners1.33%
Short Float %3.1%
Short Ratio4.84
Analysts
Analysts84
Price Target7.78 (68.03%)
EPS Next Y-284.41%
Revenue Next Year-19.62%